Brief: Clene Reports Significant Survival Benefit With CNM-Au8 Treatment in ALS EAP Compassionate Use Programs
22/02/2024 14:49
Feb 22 (Reuters) - Clene Inc. CLNN.O :
* CLENE REPORTS SIGNIFICANT SURVIVAL BENEFIT WITH CNM-AU8®
TREATMENT IN ALS EAP COMPASSIONATE USE PROGRAMS
Source text for Eikon: ID:nGNX142kMB
Further company coverage: CLNN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clene
See all newsClene Inc reports results for the quarter ended June 30 - Earnings Summary
Clene Q2 net loss widens on higher other expenses
Clene Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: Clene Inc - Enters Second Amendment To Senior Secured Convertible Notes - SEC Filing
Clene Q1 loss widens on warrant liability issuance costs